Another Biotechnology Giant to Hyderabad: CM Revanth Secures Investment Deal with Amgen

Hyderabad, Aug 9 (Maxim News): Chief Minister Revanth Reddy, currently on a visit to the United States, is making swift progress in securing significant investments for Hyderabad. Amgen, one of America’s leading biotechnology companies, has committed to making substantial investments in the city.

Click Here To Join Us On WhatsApp

Another Biotechnology Giant to Hyderabad: Key Agreement Signed in San Francisco

In a key development, an agreement was signed between the Research and Development department of Amgen and the Telangana government in San Francisco, in the presence of CM Revanth Reddy and Industries Minister Sridhar Babu.

Amgen’s Innovation Center to Be Established in Hi-Tech City

Amgen announced plans to establish a state-of-the-art technology and innovation center in Hyderabad’s Hi-Tech City. The center will focus on advanced fields such as medicine, data sciences, and artificial intelligence (AI).

Click Here To Join Us On WhatsApp

High-Level Meetings Secure Investment Commitment

During their visit to the Amgen R&D Center in San Francisco, CM Revanth Reddy and Minister Sridhar Babu met with Dr. David Rees and Om Chattopadhyay. The company representatives responded positively to the proposal, agreeing to set up a world-class facility in Hyderabad.

Job Opportunities and Hyderabad’s Growing Tech Hub Status

The establishment of this center is expected to create 3,000 job opportunities, further cementing Hyderabad’s reputation as a hub of innovation and technology. Amgen, a global leader in biotechnology for over 40 years, expressed enthusiasm about expanding its footprint in India.

Click Here To Join Us On WhatsApp

CM Revanth Reddy Welcomes Amgen’s Decision

CM Revanth Reddy welcomed the move, stating that Amgen’s decision to open an innovation center in Hyderabad is a significant step forward. He highlighted the city’s growing status as a center for innovation and technology and praised Amgen’s commitment to serving patients worldwide. (Maxim News)


Next Story :

Leave A Reply

Your email address will not be published.